Drug Type AAV based gene therapy |
Synonyms human F9 gene therapy (LogicBio Therapeutics/NIH/University of Sydney/ Stanford University School of Medicine) |
Target |
Mechanism factor IX stimulants(Coagulation factor IX stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia B | Preclinical | US | - | |
Hemophilia B | Preclinical | US | - | |
Hemophilia B | Preclinical | AU | - | |
Hemophilia B | Preclinical | US | - | |
Nonalcoholic Steatohepatitis | Preclinical | US | - |